Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
05th October 2021
We've definitely seen more cases of myopia in children (short-sightedness) this year, quite possibly due to more screen time in the past 18 months. It's easy to say - "reduce screen time" - but we kno...Read more